• Cancer-sniffing Dogs May Help Train Robot Noses to Detect Tumors Early
  • Prolaris Test Helps ID Higher-risk Patients Who May Safely Skip ADT
  • Erleada-Zytiga Combo Delays Progression in mCRPC Patients, Phase 3 Trial Reports
  • Erleada-ADT Combo Found to Prolong Survival, Delay Cancer Worsening
  • ‘TRUE Love’ Contest Calls for Entries Honoring Caregivers
  • New AI Tool May Better Predict Relapse After Surgery
  • Dosing Begins in Phase 1 Trial of FT-7051 for Advanced, Resistant Cancer
  • NBA Teams Join Efforts to Raise Money and Awareness
  • Biological Clock Protein CRY-1 Eyed as Therapeutic Target
  • EPI-7386 Combo Therapies Enter Trial for Certain mCRPC Patients
  • Daily Coffee Drinking Lowers Prostate Cancer Risk, Study Suggests
  • Active Surveillance Safe for Black Men With Low-risk Diagnosis, Study Finds